Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Lattuada

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Le Infezioni in Medicina|March 24, 2007
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected womenMassimiliano Lanzafame, Andrea Delama, Emanuela Lattuada, et al.
Le Infezioni in Medicina|June 24, 2014
[Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital]Enrico Costa, Valeria Biasi, Ercole Concia, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|April 22, 2024
HIV screening of migrants in the autonomous Province of Trento (North-Eastern Italy)Massimiliano Lanzafame, Giovanni Mori, Emanuela Lattuada, et al.
Frontiers in Endocrinology|May 30, 2019
Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ARTElisa Dalla Grana, Fabio Rigo, Massimiliano Lanzafame, et al.
International Journal of STD & AIDS|October 21, 2020
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitorDaniela Piacentini, Massimiliano Lanzafame, Sebastiano Rizzardo, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Short-cycle therapy in HIV-infected adults: rilpivirine combination 4 days on/3 days off therapyDora Luise, Emanuela Lattuada, Sebastiano Rizzardo, et al.
The New Microbiologica|October 13, 2018
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus DolutegravirMassimiliano Lanzafame, Stefano Nicole, Sebastiano Rizzardo, et al.
AIDS Research and Human Retroviruses|September 10, 2011
Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progressionMaciej Tarkowski, Laurenzia Ferraris, Sara Martone, et al.
Frontiers in Neurology|October 10, 2018
HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β<sub>2</sub>-Microglobulin a Missing Piece of the Pathogenetic Puzzle?Donato Zipeto, Michela Serena, Simona Mutascio, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE studyMaria Mazzitelli, Claudia Cozzolino, Dina Yaacoub, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Le Infezioni in Medicina|March 24, 2007
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected womenMassimiliano Lanzafame, Andrea Delama, Emanuela Lattuada, et al.
Le Infezioni in Medicina|June 24, 2014
[Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital]Enrico Costa, Valeria Biasi, Ercole Concia, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|April 22, 2024
HIV screening of migrants in the autonomous Province of Trento (North-Eastern Italy)Massimiliano Lanzafame, Giovanni Mori, Emanuela Lattuada, et al.
Frontiers in Endocrinology|May 30, 2019
Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ARTElisa Dalla Grana, Fabio Rigo, Massimiliano Lanzafame, et al.
International Journal of STD & AIDS|October 21, 2020
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitorDaniela Piacentini, Massimiliano Lanzafame, Sebastiano Rizzardo, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Short-cycle therapy in HIV-infected adults: rilpivirine combination 4 days on/3 days off therapyDora Luise, Emanuela Lattuada, Sebastiano Rizzardo, et al.
The New Microbiologica|October 13, 2018
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus DolutegravirMassimiliano Lanzafame, Stefano Nicole, Sebastiano Rizzardo, et al.
AIDS Research and Human Retroviruses|September 10, 2011
Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progressionMaciej Tarkowski, Laurenzia Ferraris, Sara Martone, et al.
Frontiers in Neurology|October 10, 2018
HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β<sub>2</sub>-Microglobulin a Missing Piece of the Pathogenetic Puzzle?Donato Zipeto, Michela Serena, Simona Mutascio, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE studyMaria Mazzitelli, Claudia Cozzolino, Dina Yaacoub, et al.
Pageof 4